BioInvent proposes rights offering

BioInvent International AB (SSE:BINV), Lund, Sweden Business: Cardiovascular, Cancer, Antibodies Date announced: 2/14/12 Type: Rights offering To be raised: SEK104.8 million ($15.8 million) Shares: 6....